Target intelligence / Profile preview

long intergenic non-protein coding RNA 83 (LINC00083)

Target
LINC00083
Molecular classification
Other (non-protein coding RNA; not a C-type lectin receptor or family member by characterized action)
01

Overview

CLEC20A, most accurately described as "long intergenic non-protein coding RNA 83 (LINC00083)," is a genomic locus annotated as a noncoding RNA with no proven protein product, biological function, or association with known molecular families such as C-type lectin receptors. While its name suggests membership in the C-type lectin domain family, there is no evidence CLEC20A encodes a membrane protein, receptor, or glycoprotein related to immune response, as is seen with CLEC12A or CLEC2A[3]. The present nomenclature and alternative names appear to be artifacts of genomic annotation and not an indication of molecular or functional classification, meaning CLEC20A should not be considered a classical molecular target or receptor. If your inquiry pertains to the characterized C-type lectin receptors (such as CLEC12A or CLEC2A), those are protein-coding genes involved in immune response and considered valid therapeutic targets[1][3]. CLEC20A/LINC00083 does not currently fit this description and is likely a misannotation or ambiguous synonym.

Other names
CLEC20AFLJ44005RP4-593C16.2LINC00083NCRNA00083putative C-type lectin domain family 20 member Along intergenic non-protein coding RNA 83
02

Mechanism of action

None

03

Biological functions

Unknown; as a lincRNA, possible regulatory functions in transcription or chromatin modification, but no established biological role in literature
04

Disease associations

None established; no evidence for involvement in cancer, inflammation, or other diseases
05

Safety considerations

None reported
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on long intergenic non-protein coding RNA 83 (LINC00083).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on long intergenic non-protein coding RNA 83 (LINC00083).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call